Reported 1 day ago
BrainAurora Medical Technology made its Hong Kong debut with shares trading flat at HK$3.22, amidst hopes for the city to regain its IPO leadership in 2025. The company's listing valued it at US$525 million and attracted significant interest from retail investors. Despite being unprofitable for three years, BrainAurora aims to channel IPO proceeds into research and development. With improved listing rules, experts predict an exciting year for Hong Kong's IPO activities.
Source: YAHOO